Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

Article too big to display. Click here to view on the SEC website

Cellectis (NASDAQ:CLLS)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Cellectis Charts.

Cellectis (NASDAQ:CLLS)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Cellectis Charts.

Cellectis SA News

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting
Wednesday 6 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Cellectis Provides Business Updates and Financial Results for Third Quarter 2024
Tuesday 5 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 31 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024
Thursday 31 October 2024 (3 weeks ago) • GlobeNewswire Inc.

Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress
Tuesday 22 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
Thursday 12 September 2024 (2 months ago) • Edgar (US Regulatory)

Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety
Wednesday 4 September 2024 (3 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 27 August 2024 (3 months ago) • Edgar (US Regulatory)

Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors
Tuesday 27 August 2024 (3 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 7 August 2024 (4 months ago) • Edgar (US Regulatory)

Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer
Wednesday 7 August 2024 (4 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 7 August 2024 (4 months ago) • Edgar (US Regulatory)

More Cellectis SA News Articles

Verizon Communications

Woodside Petroleum

National Australia Bank

JP Morgan Chase

Commonwealth Bank Of Aus...

Australian SE All Ordina...

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions